Idiopathic anaphylaxis (IA) is a life-threatening disease. It is also a disease that often is misdiagnosed. The costs of hospital visits and laboratory workup can be exorbitant before a diagnosis is made. As awareness increases, the medical community needs to be informed regarding this underdiagnosed disease so that more patients may benefit from appropriate treatment. Although the understanding of the exact mechanism of IA is limited, it has proven to be a steroid responsive disease. It is also a disease for which the likelihood of remission exceeds 80% with appropriate therapy.
|Original language||English (US)|
|Number of pages||12|
|Journal||Immunology and Allergy Clinics of North America|
|State||Published - Jan 1 2001|
ASJC Scopus subject areas
- Immunology and Allergy